by Stacey Johnson | Jan 26, 2024
When does Mardi Gras come to Miami, Florida? When it’s Advanced Therapies Week (ATW). The industry-focused conference was back at the Miami Convention Centre in South Beach, but possibly for the last time as the conference is moving to San Diego next year. That may...
by Cal Strode | Jan 18, 2024
About a year ago today, I covered the 2023 Alliance for Regenerative Medicine (ARM) State of the Industry Briefing for Signals. The briefing placed strong emphasis on the industry’s acceleration, driven by scientific advances that are bringing meaningful developments...
by Krystal Jacques | Jan 10, 2024
The Second World War (WWII) and post WWII saw an appetite for new technology and science. In particular, after WWII scientists were encouraged to conduct research for the sake of knowledge and to benefit society. However, there weren’t as many opportunities outside of...
by Stacey Johnson | Jan 5, 2024
If you only read one post for 2023, please make it this one. Below are the 10 most popular posts from last year, as determined by views recorded on the website. These are not my favourite posts, although I like all of them; this ranking is completely unbiased and...
by Stacey Johnson | Dec 29, 2023
It’s been a busy year in the cell and gene therapy community and the bloggers at Signals have enjoyed putting the spotlight on news (HeLa settlement and UK rejoins Horizon Europe), scientific advances (improving treatment for hematological malignancies and a new...
by Tyler Wenzel | Dec 21, 2023
I can recall the first time that I heard about the idea of gene therapy. It was over 20 years ago, and possibly like many students in school, I was assigned to write an essay on the ethical considerations for allowing or disallowing gene editing on humans. I remember...
by Peace Chukwu | Dec 14, 2023
When Caitlin Brodnick tested positive for the BRCA1 gene mutation, she decided to have a preventative double mastectomy. But she was afraid of losing her breasts and worried about the reconstruction, and top on the list was how real they were going to look....
by Stacey Johnson | Dec 8, 2023
Kudos to the clever team at Venair for coming up with the following post on their LinkedIn page: Although I’m tempted to discuss this from a public relations/marketing lens, instead I’m adding these to the list of great gift ideas for the scientist or science lover in...
by Stacey Johnson | Dec 1, 2023
Do you remember the column “Life, Interrupted” by cancer patient Suleika Jaouad? She was 22 when she was diagnosed with acute myeloid leukemia (AML) and a rare blood disorder called myelodysplastic syndrome. With her hopes to be a war correspondent on hold (dashed?),...
by Tyler Wenzel | Nov 23, 2023
Cell therapies that replenish a healthy cell niche have long been an attractive approach to treat a variety of diseases, such as Parkinson’s disease, which are incurable and characterized by the loss of critical cell functions. The attractiveness of cell therapies is...
Comments